Anti-cancer agents and methods
US7015225B1 · kind B1 · utility
2Cited by
0References
14Claims
0Family size
Inventor
Key dates
| Filing date | Jun 26, 2003 |
| Grant date | Mar 21, 2006 |
| Priority date | — |
| Expiry date | Apr 5, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Derivatives of retinamide are potent and selective apoptosis-inducing agents. These compounds exhibit antitumor properties and as such can be used in the treatment of cancer and other hyperproliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.